StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
SRXHSRX Global Inc.
stockpulse.co.kr
NYSE
$1.08▲ 0.47%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $21.1MShares out 19.5M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

27
  • 10.7Pre-market26.10.07 21:05
    8-KKey event#●●●#●●●

    SRX Global Inc.

    SRX Global Inc. has entered into a stock purchase agreement to acquire CERo Therapeutics from CERo Therapeutics Holdings. The consideration includes the issuance of $1 million in common stock, the discharge of $8.25 million in existing promissory note debt, and the assumption of approximately $1.56 million in liabilities. A 30-day 'go-shop' period has been established to allow for the solicitation of superior acquisition proposals.…more

    $1.08+0.47%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.6After-hours26.10.07 05:05
    8-KKey event

    SRX Global Inc.

    SRX Global announced a $1.5 million commitment to launch a new family of AI-powered actively managed ETFs through its EMJX platform in partnership with Kupa Inc. The company expects the first ETF to be available in the first quarter of 2027 and intends to distribute its holdings from the ETF launch to shareholders as a dividend.…more

    $1.08+0.47%vs prev close
    View filingShare
  • 9.9Regular26.09.10 04:00
    8-KKey event

    SRX Global Inc.

    SRX Global Inc. has secured consent from required holders to implement a stock repurchase plan, allowing the company to buy back up to $20 million worth of common stock through July 7, 2027. Under this agreement, the company is authorized to repurchase the lesser of 10 million shares or 50% of its issued and outstanding common stock, while amending certain restrictive covenants from its previous securities purchase agreement.…more

    $1.08+0.47%vs prev close
    View filingShare

26 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.8Pre-market26.10.08 21:35
    #●●●#●●●#●●●

    SRX Global Partners with 5T Trading to Launch Multi-Strategy Trading Platform…more

    SRX Global is investing $2.5 million to launch a multi-strategy trading platform in partnership with 5T Trading, powered by its EMJX technology. The initiative aims to provide infrastructure and capital to cultivate the next generation of proprietary traders.…more

    $1.08+0.47%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 10.7Regular26.10.08 04:00

    ●●●●●●●● ●●●●● ●●●●●●

    SRX Global has entered into a definitive agreement to acquire CERo Therapeutics, a company developing engineered T cell therapies for hematologic malignancies. The transaction aims to accelerate CERo's clinical development programs and enhance its access to capital.…more

    $1.08+0.47%vs prev close
    Read sourceShareGlobeNewswire
  • 10.7Pre-market26.10.07 21:11

    ●●●●●●●● ●●●●● ●●●●●●

    SRX Global has entered into a stock purchase agreement to acquire all outstanding shares of Cero Therapeutics. This transaction marks a full acquisition of the company by SRX Global.…more

    $1.08+0.47%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →